He aha ʻo Adalimumab-aaty: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

ʻO Adalimumab-aaty he mana biosimilar o ka lāʻau lapaʻau kaulana ʻo adalimumab, i hoʻolālā ʻia e mālama i nā maʻi autoimmune like ʻole ma ka hoʻomaha ʻana i ka ʻōnaehana pale o kou kino. E noʻonoʻo iā ia he lāʻau lapaʻau i hoʻopaʻa ʻia e kōkua ana i ka hoʻihoʻi ʻana i ke kaulike ke hoʻouka hewa ʻia kou ʻōnaehana pale i kāu mau ʻiʻo olakino ponoʻī.

No kēia lāʻau lapaʻau i kahi papa i kapa ʻia ʻo TNF blockers, e hana ana ma ka ālai ʻana i kahi protein kikoʻī e hoʻoulu ai i ka mumū i nā maʻi e like me ka rheumatoid arthritis, Crohn's disease, a me psoriasis. E loaʻa iā ʻoe ma ke ʻano he injection ma lalo o kou ʻili, maʻamau i hoʻokahi manawa i kēlā me kēia pule ʻelua a i ʻole i kēlā me kēia mahina, ma muli o kou maʻi.

He aha ʻo Adalimumab-aaty?

ʻO Adalimumab-aaty ka mea a nā kauka e kapa ai he lāʻau

ʻO nā maʻi maʻamau e mālama ʻia e ia, ʻo ia ka maʻi ʻāʻī rheumatoid, kahi e kōkua ai i ka hōʻemi ʻana i ka ʻeha hui a me ka pehu e hiki ke hōʻino i kou mau hui i ka wā. He mea pono nō hoʻi ia no ka psoriasis, e kōkua ana i ka hoʻomaʻemaʻe ʻana i nā pā mānoanoa a me ka unahi e ʻike ʻia ma kou ʻili.

No nā maʻi digestive, hiki i kēia lāʻau lapaʻau ke hoʻololi i ke ola no ka poʻe me ka maʻi Crohn a i ʻole ulcerative colitis. Kōkua ia i ka hoʻōla ʻana i ka mumū i loko o kou ʻōpū a hiki ke hōʻemi i nā hōʻailona e like me ka ʻeha o ka ʻōpū, ka maʻi maʻi, a me ke kahe ʻana.

ʻO nā maʻi ʻē aʻe e mālama ai kāu kauka me adalimumab-aaty, ʻo ia ka ankylosing spondylitis (he ʻano arthritis e pili ana i kou iwi kuamoʻo), psoriatic arthritis, a me kekahi mau maʻi maka e like me ka uveitis. I nā keiki, hoʻohana ʻia ia i kekahi manawa no ka maʻi ʻāʻī juvenile i ka wā i hana ʻole ai nā lāʻau lapaʻau ʻē aʻe.

Pehea e hana ai ʻo Adalimumab-aaty?

Hana ʻo Adalimumab-aaty ma ka pale ʻana i kahi protein inflammatory kikoʻī i kapa ʻia ʻo TNF-alpha i hana nui ʻia e kāu ʻōnaehana pale i ka wā o nā maʻi autoimmune. Hana kēia protein e like me ka hōʻailona alarm e mālama ana i kāu ʻōnaehana pale i ka overdrive, e hana ana i ka mumū mau a me ka pōʻino o ka ʻiʻo.

Ke hoʻokomo ʻoe i ka adalimumab-aaty, paʻa ia i nā molekala TNF-alpha i loko o kou kahe koko a pale iā lākou mai ka hoʻoulu ʻana i ka mumū. E noʻonoʻo iā ia e like me ke kau ʻana i kahi pihi mute ma nā hōʻailona inflammatory e hana nei i kāu mau hōʻailona.

Ua manaʻo ʻia kēia lāʻau lapaʻau he lāʻau ikaika a i manaʻo ʻia, ma mua o ka lāʻau lapaʻau maʻalahi. Hoʻolālā ʻia ia no nā maʻi autoimmune maʻalahi a koʻikoʻi kahi e pono ai kāu ʻōnaehana pale i ka hoʻomaha nui ʻana e pale ai i ka pōʻino lōʻihi i kou mau ʻōpū a me nā ʻiʻo.

Hoʻomaka ka hopena i loko o 2-4 mau pule o ka hoʻomaka ʻana i ka lāʻau lapaʻau, ʻoiai ua ʻike kekahi poʻe i nā hoʻomaikaʻi ʻana i ka wā ma mua. Hoʻomohala maʻamau nā pōmaikaʻi nui ma luna o 3-6 mau mahina o ka hoʻohana mau ʻana, e like me ka hoʻomaha ʻana o nā hana inflammatory o kou kino.

Pehea wau e lawe ai iā Adalimumab-aaty?

Hele mai ʻo Adalimumab-aaty ma ke ʻano he pahu kui i hoʻopiha mua ʻia e hāʻawi ai ʻoe iā ʻoe iho ma lalo o ka ʻili, maʻamau i kou ʻūhā, ka ʻōpū, a i ʻole ka lima luna. E aʻo aku kāu hui mālama ola iā ʻoe i ke ʻano o ka hoʻokomo ʻana a kōkua iā ʻoe e ʻoluʻolu me ke kaʻina hana ma mua o kou hana ʻana ma ka home.

Hoʻokomo ka hapa nui o nā kānaka i kēia lāʻau lapaʻau i hoʻokahi manawa i kēlā me kēia pule ʻelua, akā hiki i kāu kauka ke hoʻoponopono i ka papa manawa e pili ana i kou kūlana a me ka pane. He mea nui e hoʻokomo iā ia i ka lā like i kēlā me kēia manawa e mālama i nā pae kūlike i loko o kou kahe koko.

Hiki iā ʻoe ke lawe i kēia lāʻau lapaʻau me ka ʻole o ka meaʻai, no ka mea, ua hoʻokomo ʻia ma mua o ka lawe ʻia ʻana e ka waha. Eia naʻe, pono ʻoe e mālama i nā syringes i hoʻopiha mua ʻia a i ʻole nā peni i loko o kāu pahu hau a e ʻae iā lākou e hiki i ka mahana o ka lumi no kahi o 15-30 mau minuke ma mua o ka hoʻokomo ʻana.

E hoʻololi mau i kāu mau wahi hoʻokomo e pale ai i ka huhū a i ʻole nā puʻupuʻu ma lalo o kou ʻili. E mālama i kahi āu i hoʻokomo ai i kēia manawa a koho i kahi ʻokoʻa i kēlā me kēia manawa. E hoʻomaʻemaʻe i ka wahi hoʻokomo me kahi swab waiʻona a e maloʻo loa ma mua o ka hoʻokomo ʻana.

Inā hopohopo ʻoe e pili ana i ka hoʻokomo ʻana iā ʻoe iho, e hoʻomanaʻo he lahilahi loa ka nila a ʻike ka hapa nui o nā kānaka he ʻoluʻolu ʻole ia ma mua o kā lākou i manaʻo ai. Hiki nō hoʻi i kāu mea mālama ola ke kauoha i ka ʻaila numbing inā ʻoe e ʻike nui i nā injections.

Pehea ka lōʻihi e lawe ai au iā Adalimumab-aaty?

ʻO ka lōʻihi o ka mālama ʻana iā adalimumab-aaty e ʻokoʻa nui ma muli o kou kūlana a me ka maikaʻi o kou pane ʻana i ka lāʻau lapaʻau. Nui ka poʻe me nā maʻi autoimmune maʻi e lawe iā ia no nā makahiki e mālama i ka mana o nā hōʻailona a pale i ka holomua o ka maʻi.

No nā kūlana e like me ka rheumatoid arthritis a i ʻole ka maʻi o Crohn, pono paha ʻoe i ka mālama lōʻihi no ka mea he mau maʻi maʻi kēia i kēia manawa ʻaʻohe lāʻau lapaʻau. E nānā kāu kauka i kāu pane a hoʻoponopono i ka mālama ʻana e like me ka mea e pono ai, akā ʻo ka hooki ʻana i ka wā mua e alakaʻi pinepine i ka hoʻihoʻi ʻana o nā hōʻailona.

Hiki i kekahi poʻe me ka psoriasis ke hoʻomaha mai ka lapaʻau ʻana inā maʻemaʻe loa ko lākou ʻili a noho maʻemaʻe no nā manawa lōʻihi. Eia naʻe, pono e hana mau ʻia kēia hoʻoholo me ke alakaʻi ʻana o kāu kauka, no ka mea, ʻo ka hoʻōki ʻana i ka wikiwiki hiki ke alakaʻi i nā hōʻailona rebound.

E loiloi mau kāu mea mālama ola inā e hoʻomau nā pōmaikaʻi i ka lanakila ʻana i nā pilikia. E noʻonoʻo lākou i nā mea e like me ka maikaʻi o ka mālama ʻia ʻana o kāu mau hōʻailona, ​​nā hopena ʻaoʻao āu e ʻike nei, a me nā hopena mai nā hoʻokolohua koko maʻamau e nānā ana i kāu ʻōnaehana pale.

Mai hooki i ka lawe ʻana i ka adalimumab-aaty me ka ʻole e kūkākūkā mua me kāu kauka. Hiki iā lākou ke hōʻemi mālie i kāu mahele a i ʻole e hoʻololi iā ʻoe i kahi lāʻau lapaʻau ʻē aʻe e pale ai i ka hoʻi ʻana mai o kāu mau hōʻailona.

He aha nā hopena ʻaoʻao o Adalimumab-aaty?

E like me nā lāʻau lapaʻau a pau e pili ana i kāu ʻōnaehana pale, hiki i ka adalimumab-aaty ke hana i nā hopena ʻaoʻao, ʻoiai e ʻae maikaʻi ka nui o nā kānaka. ʻO nā hopena ʻaoʻao maʻamau he maʻalahi a hiki ke mālama ʻia me ka mālama kūpono a me ka nānā ʻana.

ʻO nā hopena ʻaoʻao pinepine āu e ʻike ai, ʻo ia nā hopena ma ke kahua injection, e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha maʻalahi e hoʻoponopono maʻamau i loko o hoʻokahi a ʻelua paha lā. ʻIke kekahi poʻe i nā hōʻailona e like me ke anu, nā poʻo, a i ʻole ka luhi i ka wā e hoʻoponopono ai ko lākou kino i ka lāʻau.

Eia nā hopena ʻaoʻao maʻamau e pono ai ʻoe e makaʻala:

• Nā hopena ma ke kahua injection (ʻulaʻula, pehu, ʻū)
• Nā maʻi hanu luna e like me ke anu a i ʻole nā maʻi sinus
• Nā poʻo a me ka luhi maʻalahi
• Nausea a i ʻole ka ʻoluʻolu o ka ʻōpū
• Pāʻani ʻili a i ʻole nā ​​hopena ʻili maʻalahi
• Nā hōʻailona e like me ka maʻi flu

Hoʻomaikaʻi maʻamau kēia mau hopena ʻaoʻao maʻamau i ka wā e hoʻoponopono ai kou kino i ka lāʻau, maʻamau i loko o nā pule mua o ka lapaʻau.

ʻOi aku ka pilikia o nā hopena ʻē aʻe, akā pono e mālama koke ʻia e ke kauka. No ka mea, hoʻopilikia ka adalimumab-aaty i kou ʻōnaehana pale, ʻoi aku ka nui o ka loaʻa ʻana o nā maʻi, me kekahi mau mea e hiki ke koʻikoʻi.

Eia nā hopena ʻē aʻe e pono ai ka mālama olakino wikiwiki:

• Nā hōʻailona o ka maʻi koʻikoʻi (fiva, nā anu, ka ʻū mau, ka luhi ʻole)
• Nā hōʻailona o ka maʻi tuberculosis (ka ʻū mau, ka emi ʻana o ke kaumaha, nā hou i ka pō)
• Nā hōʻailona o nā pilikia o ke ake (melemele o ka ʻili a i ʻole nā maka, ka mimi ʻeleʻele, ka luhi nui)
• Nā hōʻailona o ka maʻi puʻuwai (pōkole o ka hanu, ka pehu ʻana o nā wāwae a i ʻole nā wāwae)
• Ke kahe ʻana o ke koko a i ʻole ka ʻeha ʻana
• Nā hopena ʻili koʻikoʻi a i ʻole nā ulu ʻili hou
• Nā hōʻailona neurological (ʻeha, ʻeha, nā loli ʻike)

E kelepona koke i kāu mea mālama ola inā loaʻa iā ʻoe kekahi o kēia mau hōʻailona koʻikoʻi, no ka mea, pono paha lākou e hoʻoponopono i ka lāʻau a i ʻole ka mālama olakino hou.

ʻO nā hopena ʻē aʻe, akā koʻikoʻi, hiki ke komo i ka hoʻāla hou ʻana o ka hepatitis B (i nā kānaka i loaʻa mua kēia maʻi), kekahi mau ʻano maʻi maʻi, a me nā hopena maʻi maʻi koʻikoʻi. E nānā kāu kauka iā ʻoe no kēia mau pilikia ma mua o ka hoʻomaka ʻana i ka lāʻau a nānā mau iā ʻoe.

ʻO wai ka mea ʻaʻole pono e lawe iā Adalimumab-aaty?

ʻAʻole palekana ʻo Adalimumab-aaty no nā mea a pau, a e nānā pono kāu kauka i kāu moʻolelo olakino ma mua o ke kau ʻana. ʻO kekahi mau maʻi olakino a me nā kūlana e hana i kēia lāʻau lapaʻau i mea pilikia a kūpono ʻole paha no kekahi poʻe.

ʻAʻole pono ʻoe e lawe iā adalimumab-aaty inā loaʻa iā ʻoe kahi maʻi ikaika, me nā maʻi koʻikoʻi e like me ka tuberculosis, a i ʻole inā e hakakā nei ʻoe i nā maʻi bacteria, viral, a i ʻole fungal. Pono e hana piha kāu ʻōnaehana pale e mālama i nā maʻi, a e hoʻopilikia kēia lāʻau lapaʻau i kēlā kaʻina hana.

Pono nā kānaka me kekahi mau maʻi maʻi mau e pale i kēia lāʻau lapaʻau. Inā loaʻa iā ʻoe ka hepatitis B, hepatitis C, a i ʻole HIV, hiki i ka hoʻohaʻahaʻa ʻana o ka ʻōnaehana pale mai adalimumab-aaty ke hoʻonui i kēia mau maʻi a i ʻole e paʻakikī ke kāohi.

Eia nā maʻi nui e pale maʻamau ai i kekahi mai ka lawe ʻana i ka adalimumab-aaty:

• Nā maʻi hana o kēlā me kēia ʻano
• Mōʻaukala o ka maʻi tuberculosis a i ʻole ka hōʻike ʻana i ka maʻi tuberculosis
• Nā maʻi viral mau (hepatitis B, hepatitis C, HIV)
• Lapaʻau maʻi maʻi i kēia manawa a i ʻole i hala koke
• ʻO ka hāʻule ʻana o ka naʻau nui
• ʻIke ʻia ka maʻi maʻi i ka adalimumab a i ʻole nā lāʻau lapaʻau like
• Nā lāʻau lapaʻau ola hou a i ʻole nā lāʻau lapaʻau ola i hoʻolālā ʻia

E akahele nō hoʻi kāu kauka i ka kuhikuhi ʻana i kēia lāʻau lapaʻau inā loaʻa iā ʻoe ka maʻi diabetes, ka maʻi kīkī mau a i ʻole ka maʻi ate, a i ʻole inā ʻoe ma luna o 65 mau makahiki, no ka mea, hiki i kēia mau mea ke hoʻonui i kou pilikia o nā pilikia.

Pono ka hāpai ʻana a me ka hānai ʻana i ka umauma i ka noʻonoʻo kūikawā. ʻOiai hiki ke hoʻohana ʻia ka adalimumab-aaty i ka wā hāpai i kekahi mau kūlana, e ana pono kāu kauka i nā pōmaikaʻi e kūʻē i nā pilikia hiki iā ʻoe a me kāu pēpē.

Inā ʻoe e hoʻolālā ana i ke ʻoki ʻana, hiki i kāu kauka ke hoʻōki i kāu lapaʻau adalimumab-aaty no ka manawa e hōʻemi i ka pilikia o ka maʻi i ka wā o ke kaʻina hana hoʻōla. E hōʻike mau i kekahi mea mālama ola e mālama ana iā ʻoe e lawe ana ʻoe i kēia lāʻau lapaʻau.

Nā inoa inoa Adalimumab-aaty

ʻO Adalimumab-aaty ka inoa generic no kēia lāʻau lapaʻau biosimilar, akā kūʻai ʻia nō hoʻi ma lalo o ka inoa inoa Hyrimoz. Hiki i kāu hale kūʻai lāʻau lapaʻau ke hāʻawi i ka mana generic a i ʻole ka mana inoa inoa, ma muli o kāu ʻinikua a me ka loaʻa.

Kūʻai ʻia ka lāʻau adalimumab mua ma lalo o ka inoa inoa Humira, a ʻike paha ʻoe iā ia mai nā hoʻolaha a i ʻole nā kauoha mua. Ua hoʻomohala ʻia ʻo Adalimumab-aaty ma ke ʻano he koho ʻoi aku ka maikaʻi i Humira me ka hāʻawi ʻana i nā pōmaikaʻi therapeutic like.

I ka wā e kauoha ai kāu kauka i kēia lāʻau lapaʻau, hiki iā lākou ke kākau i ka

Ua hoʻolālā ʻia ʻo Adalimumab-aaty e like me ka maikaʻi e like me Humira (ka adalimumab kumu) no ka mālama ʻana i nā maʻi autoimmune. Ma ke ʻano he biosimilar, pono e hōʻoia ma o nā hoʻokolohua lapaʻau nui e hana like ia me ka lāʻau kumu.

Ma ke ʻano o ka pono, hiki iā ʻoe ke manaʻo e hāʻawi ʻo adalimumab-aaty i ka hoʻomaha like ʻana o nā hōʻailona a me ka mālama ʻana i ka maʻi e like me Humira. Ua like ka mea hana a me ke ʻano o kāna hana ʻana i loko o kou kino, no laila ʻaʻole pono ka hoʻololi ʻana ma waena o lākou e pili i nā hopena o kāu mālama ʻana.

ʻO ka pōmaikaʻi nui o adalimumab-aaty ma luna o Humira ʻo ke kumukūʻai. ʻOi aku ka liʻiliʻi o nā lāʻau lapaʻau biosimilar ma mua o kā lākou mau inoa inoa, hiki ke hopena i nā copays haʻahaʻa a i ʻole nā ​​kumukūʻai mai ka ʻeke no ʻoe, ma muli o kāu ʻinikua.

Makemake kekahi poʻe i hoʻokahi formulation ma luna o kekahi ma muli o nā mea e like me ka hoʻolālā ʻana o ka mea hana injection, nā koi mālama, a i ʻole ke ʻano o ka lāʻau i ka wā e hoʻokomo ai. Eia naʻe, he mea liʻiliʻi kēia mau ʻokoʻa a hiki i ka makemake pilikino ma mua o ka maikaʻi o ka lāʻau lapaʻau.

Inā ʻoe e lawe nei iā Humira a manaʻo kāu kauka e hoʻololi i adalimumab-aaty, hiki iā ʻoe ke manaʻoʻiʻo e loaʻa ana iā ʻoe ka mālama like. He maʻalahi ka hoʻololi ʻana, me ka ʻole o ka pono e hoʻoponopono i ka dosage a i ʻole ka manawa.

Nā Nīnau i Nīnau pinepine ʻia e pili ana iā Adalimumab-aaty

Q1. Palekana ʻo Adalimumab-aaty no ka poʻe me ka maʻi diabetes?

Hiki ke hoʻohana ʻia ʻo Adalimumab-aaty e ka poʻe me ka maʻi diabetes, akā pono ia i ka nānā ʻana a me ka mālama pono. Hiki i ka maʻi diabetes ke hoʻopilikia i ka hiki o kāu ʻōnaehana pale e hakakā i nā maʻi, a hoʻopilikia hou ʻo adalimumab-aaty i ka hana immune, e hoʻonui ana i ka pilikia o ka maʻi.

E hana pū kāu kauka me ʻoe e nānā pono i nā pae kōpa koko a e nānā i nā hōʻailona o ka maʻi ma mua o ka maʻamau. Hiki paha iā lākou ke hana pū me kāu endocrinologist a i ʻole loea maʻi diabetes e hōʻoia i ka maikaʻi o kāu mālama ʻana i ka maʻi diabetes i ka wā e lawe ana i kēia lāʻau.

Nui ka poʻe me ka maʻi diabetes a me nā maʻi autoimmune e lawe pono i ka adalimumab-aaty me ka mālama olakino kūpono. ʻO ke kī, ʻo ia ka mālama ʻana i ka mana kōpa koko maikaʻi a me ka makaʻala e pili ana i ka pale ʻana i ka maʻi a me ka ʻike mua.

Q2. He aha kaʻu e hana ai inā ua hoʻohana hewa au i ka nui o ka Adalimumab-aaty?

Inā ʻoe e hoʻokomo hewa i ka adalimumab-aaty ma mua o ka mea i kauoha ʻia, e hoʻokaʻaʻike koke i kāu mea mālama ola, ʻoiai inā maikaʻi ʻoe. Hiki i ka overdose ke hoʻonui i kou pilikia o nā maʻi koʻikoʻi a me nā pilikia ʻē aʻe, no laila he mea nui ka loiloi olakino.

Mai hopohopo, akā e ʻimi koke i ka lāʻau lapaʻau. Hiki i kāu kauka ke makemake e nānā pono iā ʻoe no nā hōʻailona o ka maʻi a i ʻole nā hopena ʻē aʻe i nā pule e hiki mai ana. Hiki iā lākou ke hoʻoponopono i kāu mahele i hoʻonohonoho ʻia a i ʻole e hoʻōki i ka lāʻau no ka manawa.

E lawe mai i ka pūʻolo lāʻau me ʻoe i kāu manawa e hiki ai i kāu mea mālama ola ke hoʻoholo pololei i ka nui o ka lāʻau lapaʻau hou āu i loaʻa ai. Kōkua kēia ʻike iā lākou e loiloi i kou pilikia a hoʻolālā i ka nānā pono.

Q3. He aha kaʻu e hana ai inā ua hala au i kahi mahele o Adalimumab-aaty?

Inā ua hala ʻoe i kahi mahele o adalimumab-aaty, e hoʻokomo iā ia i ka wā e hoʻomanaʻo ai ʻoe, ke ʻole kokoke ka manawa no kāu mahele i hoʻonohonoho ʻia. I kēlā hihia, e lele i ka mahele i hala a e hoʻomau me kāu papa maʻamau ma mua o ka pāpālua ʻana.

E hoʻāʻo e hoʻi i kāu papa maʻamau i ka hiki wawe, no ka mea, ʻo nā pae paʻa o ka lāʻau i loko o kou kahe koko e kōkua i ka mālama ʻana i ka mana o nā hōʻailona. Inā ʻaʻole ʻoe maopopo e pili ana i ka manawa, e kelepona i kāu mea mālama ola a i ʻole ka mea kūʻai lāʻau lapaʻau no ke alakaʻi.

ʻAʻole pilikia koke ka nalo ʻana i kahi lāʻau i kekahi manawa, akā ʻo ka nalo ʻana i nā lāʻau he nui hiki ke hoʻi mai kou mau hōʻailona. E noʻonoʻo e hoʻonohonoho i nā mea hoʻomanaʻo kelepona a i ʻole e hoʻohana i kahi polokalamu e nānā i nā lāʻau lapaʻau e kōkua iā ʻoe e hoʻomanaʻo i kāu papa hana injection.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Adalimumab-aaty?

Pono ʻoe e hooki i ka lawe ʻana iā adalimumab-aaty ma lalo o ka mālama ʻana a kāu kauka, ʻoiai inā ʻoe e manaʻo maikaʻi ana. Pono ka hapa nui o nā maʻi autoimmune i ka mālama mau ʻana e pale ai i ka hoʻi ʻana mai o nā hōʻailona a e pale aku i ka pōʻino o nā ʻōkana i ka wā lōʻihi.

E loiloi mau kāu kauka inā pono ʻoe i ka lāʻau lapaʻau ma ka loiloi ʻana i kāu mau hōʻailona, ​​e hana ana i nā hoʻokolohua kino, a me ka loiloi ʻana i nā hoʻokolohua lab. Hiki iā lākou ke noʻonoʻo e hōʻemi i ka mahele a i ʻole e hoʻolōʻihi i ka manawa ma waena o nā injections ma mua o ka hooki ʻana.

Hiki i kekahi poʻe ke hooki pono i ka adalimumab-aaty inā ua noho lākou i ka remission no nā manawa lōʻihi, akā pono kēia hoʻoholo i ka loiloi lapaʻau akahele. E hana kāu kauka i kahi hoʻolālā no ka nānā ʻana i kou kūlana ma hope o ka hooki ʻana i mea e hopu ai i ka hoʻi ʻana mai o nā hōʻailona.

Q5. Hiki iaʻu ke kiʻi i nā lāʻau lapaʻau i ka wā e lawe ana iā Adalimumab-aaty?

Hiki iā ʻoe ke loaʻa ka hapa nui o nā lāʻau lapaʻau i ka wā e lawe ana iā adalimumab-aaty, akā pono ʻoe e pale loa i nā lāʻau lapaʻau ola. Loaʻa i nā lāʻau lapaʻau ola nā maʻi maʻi a i ʻole nā ​​bacteria i nāwaliwali akā e ola ana e hiki ke hoʻoulu i nā maʻi koʻikoʻi ke hoʻopau ʻia kāu ʻōnaehana pale.

ʻO nā lāʻau lapaʻau i hoʻopau ʻia (e like me ka pana flu, ka lāʻau lapaʻau pneumonia, a i ʻole nā ​​lāʻau lapaʻau COVID-19) palekana a paipai ʻia i ka wā e lawe ana iā adalimumab-aaty. Eia naʻe, ʻaʻole paha lākou e hana maikaʻi e like me ka hana ʻana me kahi ʻōnaehana pale e hana pono ana.

E hoʻomaopopo mau i kekahi mea mālama ola e hāʻawi ana iā ʻoe i nā lāʻau lapaʻau e lawe ana ʻoe iā adalimumab-aaty. Hiki iā lākou ke aʻo iā ʻoe i ka manawa o ka lāʻau lapaʻau a kōkua e hōʻoia e loaʻa ana iā ʻoe nā immunizations pale loa no kou kūlana i ka wā e palekana ana.